Inflexion has agreed to make a minority investment in Phenna Group (Phenna), a business focused on the testing, inspection, certification and compliance (TICC) sector.
Inflexion has agreed to make a minority investment in Phenna Group (Phenna), a business focused on the testing, inspection, certification and compliance (TICC) sector. The investment is being made by Inflexion’s dedicated minority investment fund, Partnership Capital II, and follows our recent minority investment in Spanish business services company Auxadi earlier this year.
Formed in 2018 and headquartered in the UK, Phenna consists of a broad range of TICC businesses currently serving industrial manufacturing, built environment, construction and property end markets. The company will continue to consolidate the highly fragmented TICC industry by acquiring select niche, independent TICC businesses that serve a diverse range of sectors in the UK and internationally.
Inflexion is well positioned to help Phenna achieve its ambitious growth plans due to its deep experience in this sector following investments in Alcumus, British Engineering Services and Cawood Scientific. Inflexion will also utilise its experience to support the company’s growth through M&A to expand Phenna’s existing service offering and geographical reach.
Paul Barry, CEO, Phenna, says: “I have known the Inflexion team for a long time and I am delighted to be partnering with them for the next step in Phenna’s journey. Inflexion stood out as their Partnership Capital offering allows the current shareholders to retain majority control, whilst benefiting from their resources and very relevant experience in our sector.”
Simon Turner, Managing Partner, Inflexion, adds: “Paul and the team have built a very successful business in a short space of time. We have been particularly impressed with their strong track record of backing niche market leaders and making successful acquisitions. We are delighted to get the opportunity to partner with the team to accelerate this growth further both in the UK and internationally.”
The investment is subject to regulatory approval.
